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Abstract
Background: Human mast cells are capable of a wide variety of inflammatory responses and play a vital role in
the pathogenesis of inflammatory diseases such as allergy, asthma, and atherosclerosis. We have reported that
cigarette smoke extract (CSE) significantly increased IL-6 and IL-8 production in IL-1b-activated human mast cell
line (HMC-1). Baicalein (BAI) has anti-inflammatory properties and inhibits IL-1b- and TNF-a-induced inflammatory
cytokine production from HMC-1. The goal of the present study was to examine the effect of BAI on IL-6 and IL-8
production from CSE-treated and IL-1b-activated HMC-1.
Methods: Main-stream (Ms) and Side-stream (Ss) cigarette smoke were collected onto fiber filters and extracted in
RPMI-1640 medium. Two ml of HMC-1 at 1 × 10
6 cells/mL were cultured with CSE in the presence or absence of
IL-1b (10 ng/mL) for 24 hrs. A group of HMC-1 cells stimulated with both IL-1b (10 ng/ml) and CSE was also
treated with BAI. The expression of IL-6 and IL-8 was assessed by ELISA and RT-PCR. NF-B activation was
measured by electrophoretic mobility shift assay (EMSA) and IBa degradation by Western blot.
Results: Both Ms and Ss CSE significantly increased IL-6 and IL-8 production (p < 0.001) in IL-1b-activated HMC-1.
CSE increased NF-B activation and decreased cytoplasmic IBa proteins in IL-1b-activated HMC-1. BAI (1.8 to 30
μM) significantly inhibited production of IL-6 and IL-8 in a dose-dependent manner in IL-1b-activated HMC-1 with
the optimal inhibition concentration at 30 μM, which also significantly inhibited the enhancing effect of CSE on IL-
6 and IL-8 production in IL-1b-activated HMC-1. BAI inhibited NF-B activation and increased cytoplasmic IBa
proteins in CSE-treated and IL-1b-activated HMC-1.
Conclusions: Our results showed that CSE significantly increased inflammatory cytokines IL-6 and IL-8 production
in IL-1b-activated HMC-1. It may partially explain why cigarette smoke contributes to lung and cardiovascular
diseases. BAI inhibited the production of inflammatory cytokines through inhibition of NF-B activation and IBa
phosphorylation and degradation. This inhibitory effect of BAI on the expression of inflammatory cytokines induced
by CSE suggests its usefulness in the development of novel anti-inflammatory therapies.
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Human mast cells, which are associated with allergies,
asthma, and atherosclerosis, are multifunctional cells
capable of inflammatory responses producing and
secreting a wide variety of lipid mediators, histamine,
cytokines, and chemokines [1,2]. Mast cells have been
implicated in acute and chronic inflammatory responses
and in many diseases characterized by inflammation [3].
The fact that mast cells accumulate at sites of inflamma-
tion, such as the nasal mucosa of patients with allergic
rhinitis [4], the lung smooth muscle of patients with
asthma [5], the skin of patients with urticaria [6], and
the joints of patients with arthritis [7], illustrates the
association of mast cells in these inflammatory diseases
[8]. Our previous reviews have summarized the impor-
tant role mast cells play in allergic, asthmatic, and
inflammatory responses, conditions caused by the pro-
duction of mediators and select inflammatory cytokines
[1,2].
Interleukin-6 (IL-6) and interleukin-8 (IL-8) are impor-
tant inflammatory cytokines that are secreted from acti-
vated mast cells. IL-6 is a multifunctional protein. In
innate immunity, it stimulates the synthesis of acute-
phase proteins by hepatocytes and thus contributes to
the systemic effects of inflammation [9]. In adaptive
immunity, it stimulates the growth of B cells that have
differentiated into antibody producers [10]. IL-8 is a
potent neutrophil chemotactic and activating factor. It
serves as a chemical signal that attracts neutrophils to
the site of inflammation [11]. IL-1b is secreted mainly by
macrophages. IL-1b is produced in response to various
stimulants, such as bacteria, viruses, and cytokines [12].
Our previous studies have shown IL-1b activated human
mast cells produce selected inflammatory cytokines
[13,14].
The Centers for Disease Control and Prevention
reported that the adverse health effects from cigarette
smoking account for an estimated 438,000 deaths or
nearly 1 out of every 5 deaths each year in the United
States. Cigarette smoking is linked to cancer, cardiovascu-
lar disease, respiratory disease, and other adverse effects.
Epidemiological studies also show that cigarette smoking
increases the risk of atherosclerosis [15]. Unfortunately,
the underlying basic mechanisms involved in the processes
that lead to diseases induced by cigarette smoke compo-
nents is not much known. Previously, we have reported
that cigarette smoke extract (CSE) significantly increased
IL-6 and IL-8 production in IL-1b-activated human mast
cell-1 (HMC-1). The first goal of this study was to exam-
ine effects and mechanisms of CSE on the expression of
inflammatory cytokines in mast cells. Studying mast cell
responses to CSE may lead to a greater understanding of
cigarette smoke induced diseases.
Baicalein (BAI) is a flavonoid originally isolated from
the roots of the traditional Chinese herbal medicine
Huangqin, Scutellaria baicalensis Georgi. It has been
widely employed for many centuries in the traditional
Chinese herbal medicine as popular antibacterial, anti-
viral, and anti-inflammatory agents [16]. Historically,
Scutellaria baicalensis has been used to treat respiratory
tract infection, diarrhea, jaundice, and hepatitis. Recent
investigations showed it had broad anti-inflammatory
activities. BAI suppressed the LPS-induced production of
NO in RAW 264.7 mouse macrophages [17]. It was
shown to have potent neuroprotective effect on LPS-
induced injury of dopaminergic neurons [18]. Recently,
BAI has been shown to inhibit inflammation through
inhibition of COX-2 gene expression [19] and to sup-
press LPS induced degradation of IBa and activation of
NF-B [20]. Recently, our group has reported that Baica-
lein inhibits IL-1b-a n dT N F - a-induced inflammatory
cytokine production from human mast cells via regula-
tion of NF-B pathway [21]. The second goal of this
study is to investigate effects and mechanisms of BAI on
inflammatory cytokine expressions from CSE treated and
IL-1b-activated human mast cells. Our results showed
that BAI inhibited the enhanced effects of CSE on
expression of inflammatory cytokines through inhibition
of NF-B activation and IBa phosphorylation and
degradation in human mast cells. This inhibitory effect of
BAI on the expression of inflammatory cytokines sug-
gests its usefulness in the development of novel anti-
inflammatory therapies.
Methods
Reagents and cells
The baicalein was purchased from Sigma (St. Louis, MO).
The HMC-1 cell line, established from a patient with mast
cell leukemia, was graciously provided by Dr. Joseph H.
Butterfield (Mayo Clinic,R o c h e s t e r ,M N ) .I L - 1 b and
ELISA kits of IL-6, and IL-8 were purchased from R&D
(Minneapolis, MN). RPMI 1640 media and HEPES were
obtained from GibcoBRL (Rockville, MD). 2-mercap-
toethanol was purchased from Sigma (St. Louis, MO).
Fetal bovine serum was obtained from Atlanta Biologicals
(Atlanta, GA). RNA-BEE was purchased from Tel-Test,
Inc. (Friendswood, Texas). Gene Amp RNA PCR Core Kit
was purchased from Applied Biosystems (Branchburg, NJ).
Cigarette smoke extract
An ignited cigarette was placed in a 3.1 L bell-shaped
glass vessel, the Sidestream smoke (Ss) within the vessel
was pumped out of the bell and collected onto quartz
fiber filters. Mainstream smoke (Ms) was collected
directly from the cigarette onto quartz fiber filters using
ap u f fv o l u m eo f3 5m li n2s e c o n d sa tar a t eo f8p u f f s
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smoke collection and the increase in weight was recorded
as cigarette smoke weight. The cigarette smoke was
extracted from the filters with RPMI 1640 medium to a
concentration of 5 mg/ml.
Cell culture
HMC-1 cells were cultured and maintained in RPMI
1640 media with 5 × 10
-5 2-mercaptoethanol, 10 mM
HEPES, gentamycin 50 μg/ml, 5 μg/ml insulin, transfer-
rin and sodium selenite, 2 mM L-glutamine, and 5%
heat inactivated fetal bovine serum in a 37°C incubator
with 5% CO2. The cell cultures were maintained in
75 cm
2 flasks (Corning) [22].
Induction of cytokine production
Two ml of HMC-1 mast cells at 1 × 10
6 cells/ml concen-
tration were cultured with or without different concentra-
tions of both Ms and Ss cigarette smoke extract in the
presence or absence of IL-1b (10 ng/ml) for 24 hrs [13]. A
group of HMC-1 cells stimulated with both IL-1b (10 ng/
ml) and CSE was also treated with BAI. The cultures were
carried out in triplicate. At the end of incubation, superna-
tants were harvested for measuring IL-6 and IL-8 by
ELISA and cell viability and numbers of the culture were
analyzed. The cell viability was determined by trypan blue
dye exclusion. Trypan blue dye (0.4%) was added to cell
samples in a ratio of 1:2.5 and preparations were viewed
with a standard light microscope [13]. The ratio of live to
dead cells (cell viability) was determined. The cell viabil-
ities of the drug groups and the medium control cultures
in this study were ranging from 90 to 98%. BAI, IL-1b,
and CSE at the concentrations used in this study appeared
to have no toxic effect to the HMC-1 cultures.
ELISA for cytokine production
Cytokine ELISA was performed for IL-6 and IL-8.
ELISA was carried out on cell-free culture supernatants
using commercially available ELISA kits, according to
manufacturer’s instructions as earlier described. Results
were analyzed on an ELISA plate reader (Dynatech MR
5000 with supporting software) [13].
Analysis of cytokine gene expression by RT-PCR
HMC-1 were treated with the appropriate reagents and
allowed to incubate at 37°C with 5% CO2 for 6 hours
before being harvested for RNA. RNA was extracted
f r o mH M C - 1( 3×1 0
6 cells) by the addition of 1 ml of
RNA-BEE. After the addition of chloroform and shaking
for 1 minute the samples were centrifuged at 12,000 × g
for 15 minutes at 4°C to achieve phase separation. Iso-
propanol was added to the aqueous phase, and the pre-
paration was frozen at -20°C overnight. The following
day, the samples were centrifuged at 12,000 × g for 30
minutes at 4°C. The RNA pellet was washed with 1 ml
75% ethanol containing DEPC and allowed to air dry.
The pellet was resuspended in DEPC water and quanti-
tated by optical density readings at 260 nm. Reverse
Transcriptase Polymer Chain Reaction (RT-PCR) was
performed with a Gene Amp RNA PCR Core Kit accord-
ing to manufacturer’s instructions. cDNA was synthe-
sized with murine leukemia virus reverse transcriptase
(2.5 U/μl), 10× PCR buffer (500 mM KCl, 100 mM Tris-
HCl, pH 8.3), 1 mM each of the nucleotides dATP,
dCTP, dGTP and dTTP; RNase inhibitor (1 U/μl), MgCl2
(5 mM), and oligo(dT)16 (2.5 μM) as a primer. The sam-
ples were incubated at 42°C for 20 minutes, 99°C for 20
minutes, and 5°C for 5 minutes in a DNA thermocycler
(Perkin-Elmer Corp., Norwalk, CT) for reverse transcrip-
tion. PCR of cDNA was done with MgCl2 (1.8 mM), each
of the dNTPs (0.2 mM), AmpliTaq polymerase (1 U/50
μl), and paired cytokine-specific primers (0.2 nM of each
primer) to a total volume of 50 μl. Cycles consisted of
1 cycle of 95°C for 2 min, 35 cycles of 95°C for 45 sec,
60°C for 45 sec, and 72°C for 1 min 30 sec, and lastly, 1
cycle of 72°C for 10 min. Ten microliters of the sample
were electrophoresed on a 2% agarose gel and stained
with ethidium bromide for viewing. Primer sequences
used are as follows: HPRT: 5’ CGA GAT GTG ATG
A A GG A GA T GG3 ’ and 5’ GGA TTA TAC TGC CTG
ACC AAG G 3’;I L - 6 :5 ’ ATG AAC TCC TTC TCC
ACA AGC GC 3’ and 5’ GAA GAG CCC TCA GGC
T G GA C TG3 ’;a n dI L - 8 :5 ’ ATG ACT TCC AAG CTG
GCC GTG GCT 3’ and 5’ TCT CAG CCC TCT TCA
AAA ACT TCT C 3’. Densitometry was done by normal-
izing target genes to house keepers using Un-Scan-It
Version 5.1 software (Orem, UT) [21].
NF-B assay in HMC-1
HMC-1 were stimulated with IL-1b, CSE, and/or BAI for
30 minutes, and then harvested for isolation of nuclear
and cytoplasmic proteins according our previously
reported method [21]. Nuclear translocation of NF-B
was analyzed by the electrophoretic mobility shift assay
(EMSA) using the nuclear proteins [23-26]. Cells were
washed with PBS and mixed with one hundred microliters
of hypotonic buffer which contains: 10 mM HEPES pH
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluor-
ide (PMSF), 1 μMa p r o t i n i n ,1μM pepstatin, 14 μM leu-
peptin, 50 mM NaF, 30 mM b-glycerophosphate, 1 mM
Na3VO4, and 20 mM p-nitrophenyl phosphate. Cells were
incubated over ice for 30 minutes and then vortexed after
the addition of 6.25 μlo f1 0 %o fN o n i d e tP - 4 0 .A f t e r2
minutes of centrifugation at 30,000 × g, supernatants were
kept at -80°C while the pellets were collected and vortexed
every 20 minutes for 3 hours in 60 ml of a hypertonic salt
solution: 20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM
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aprotinin, 1 μM pepstatin, 14 μM leupeptin, 50 mM NaF,
30 mM b-glycerophosphate, 1 mM Na3VO4, and 20 mM
p-nitrophenyl phosphate. Nuclear translocation of NF-B
was analyzed by the EMSA using the nuclear fraction.
Seven micrograms of nuclear protein were added to 2 ml
of binding buffer (Promega, Madison, WI), and 35 fmol of
double stranded NF-B consensus oligonucleotide (5’
AGT TGA GGG GAC TTT CCC AGG C 3’)( P r o m e g a ,
Madison, WI) end labeled with g-P32 ATP (Amersham
Biosciences, Piscataway, NJ). The samples were incubated
at room temperature for 20 minutes and run on a 5% non-
denaturing polyacrylamide gel for 2 hours. A supershift
assay using antibodies to P65 and P50 was performed to
confirm NF-B binding specificity as previously described
[23-26].
Western blot analysis for IBa
Cytoplasmic proteins (40 μg) were mixed with 2x SDS
sample buffer, heated at 95°C for 5 min, and separated by
SDS-polyacrylamide (12.5%) gel electrophoresis [24,27].
The separated proteins were transferred onto Hybond
enhanced chemiluminescence membranes (Amersham)
and then incubated with an appropriate rabbit primary
antibody [IBa antibody (Santa Cruz Biotechnology) or
phosphorylated IBa antibody (New England Biolabs)] in
Tris-buffered saline - 0.05% Tween 20 containing 5%
nonfat dry milk for 1 - 2 hours at room temperature.
After they were washed three times in Tris-buffered sal-
ine - 0.05% Tween 20, the membranes were incubated
with peroxidase-conjugated goat anti-rabbit IgG (Sigma
Chemical) for 1 hour at room temperature. After three
washes in PBS, the conjugated peroxidase was visualized
by enhanced chemiluminescence according to the manu-
facturer’si n s t r u c t i o n s( A m e r s h a m ). The protein signals
of IBa were quantified by scanning densitometry
(Genomic Solutions).
Statistical analysis of the data
All experiments were done in triplicate. The data were
analyzed by Student’st w o - t a i l e dt-test using Statistica soft-
ware (StatSoft, Inc., Tulsa, OK). All data were reported as
means ± SE. A p-value of less than 0.05 was considered
significant.
Results
CSE increased IL-6 and IL-8 production in IL-1b-activated
mast cells
HMC-1 cells were cultured with IL-1b (10 μg/mL) and
various concentration of CSE for 24 hours. The medium
alone did not induce IL-6 and IL-8 production in HMC-1
cells (Figures 1, 2, 3 and 4). As the previous report, IL-1b
at 10 ng/mL concentration markedly induced IL-6 and IL-
8 production from HMC-1, while the mainstream (Ms)
and sidestream (Ss) CSE either did not or only produced
trace of cytokines (Figures 1, 2, 3 and 4). The effect of Ms
C S Eo np r o d u c t i o no fI L - 6w a ss h o w ni nF i g u r e1 .T h e
Ms CSE at 31.25 to 250 μg/mL concentrations signifi-
cantly increased IL-6 production in IL-1b-activated HMC-
1 cells. The Ss CSE also increased production of IL-6 in
IL-1b-activated HMC-1 cells (Figure 2). Similarly, both Ms
and Ss CSE increased production of IL-8 in a dose-depen-
dent fashion in IL-1b-activated HMC-1 cells (Figures 3
and 4).
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Figure 1 Effects of Mainstream cigarette smoke extract (Ms) on
IL-6 production from IL-1b-activated HMC-1 cells.T oe a c hw e l lo fa
6-well culture plate, two ml of HMC-1 (1 × 10
6 cells/ml) were cultured
alone (Medium), or in the presence of IL-1b (10 ng/ml), and the
combinations of IL-1b with different concentrations of Ms for 24 hrs in
triplicate. Supernatants were harvested for measuring IL-6 by ELISA.
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compared to IL-1β
+
+ +
Medium
Ss
IL-1β
IL-1β + Ss (250 μg/ml)
IL-1β + Ss (125 μg/ml)
IL-1β + Ss (62.5 μg/ml)
IL-1β + Ss (31.25 μg/ml)
Figure 2 Effects of Sidestream cigarette smoke extract (Ss) on IL-
6 production from IL-1b-activated HMC-1 cells. To each well of a 6-
well culture plate, two ml of HMC-1 (1 × 10
6 cells/ml) were cultured
alone (Medium), or in the presence of IL-1b (10 ng/ml), and the
combinations of IL-1b with different concentrations of Ss for 24 hrs in
triplicate. Supernatants were harvested for measuring IL-6 by ELISA.
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production in IL-1b-activated mast cells
The effect of BAI on production of IL-6 and IL-8 from
IL-1b-activated HMC-1 cells was studied. BAI at con-
centrations of 1.8, 3.6, 7.5, 15, and 30 μM have been
proved to be non-toxic to HMC-1 [28]. Two mL of
HMC-1 at 1 × 10
6 cells/mL were cultured with the
above mentioned concentrations of BAI in the presence
or absence of IL-1b (10 ng/mL) for 24 hrs. The culture
supernatants were collected and assayed for cytokines
by ELISA. BAI alone did not induce cytokine production
from HMC-1. However, BAI at 15 and 30 μM concen-
trations significantly decreased the IL-6 production to
192.7 ± 18.7 and 74.6 ± 14.6 pg/mL, respectively (p <
0.0005 and p < 0.00005, respectively) (Figure 5A). BAI
at all tested concentrations (1.8 to 30 μM) significantly
decreased the IL-1b-induced IL-8 production, in a dose-
dependent manner, to 316.4 ± 1.3, 177.4 ± 13.2, 147.6 ±
5.4, 54.9 ± 3.3, and 46.9 ± 4.4 pg/mL, respectively (p <
0.05 for 1.8 μM, p < 0.0005 for 3.6 μM, and p < 0.00005
for all the rest) (Figure 5B). Since BAI at 30 μM was the
most effective concentration in inhibition of cytokine
production in IL-1b-activated HMC-1, we decided to
only use this concentration in experiments with CSE-
treated HMC-1.
In order to investigate the effect of BAI on the enhan-
cing effects CSE has on IL-6 and IL-8 production in
IL-1b-activated mast cells, we treated the HMC-1 cells
with or without IL-1b a n dC S Ei nt h ep r e s e n c eo r
absence of BAI (30 μM). BAI significantly inhibited the
enhancing effect of both Ms and Ss CSE on production
of IL-6 in IL-1b-activated HMC-1 (Figures 6 and 7).
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Figure 3 Effects of Mainstream cigarette smoke extract (Ms) on
IL-8 production from IL-1b-activated HMC-1 cells.T oe a c hw e l lo fa
6-well culture plate, two ml of HMC-1 (1 × 10
6 cells/ml) were cultured
alone (Medium), or in the presence of IL-1b (10 ng/ml), and the
combinations of IL-1b with different concentrations of Ms for 24 hrs in
triplicate. Supernatants were harvested for measuring IL-8 by ELISA.
Medium
Ss
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Figure 4 Effects of Sidestream cigarette smoke extract (Ss) on
IL-8 production from IL-1b-activated HMC-1 cells. To each well
of a 6-well culture plate, two ml of HMC-1 (1 × 10
6 cells/ml) were
cultured alone (Medium), or in the presence of IL-1b (10 ng/ml),
and the combinations of IL-1b with different concentrations of Ss
for 24 hrs in triplicate. Supernatants were harvested for measuring
IL-8 by ELISA.
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Figure 5 Effects of Baicalein (BAI) on production of IL-6 (A) and
IL-8 (B) from IL-1b-activated HMC-1 cells. (*, +, and # indicate p
< .05, < .0005, and < .00005, respectively, when compared with the
IL-1b-treated group)
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effect of both Ms and Ss CSE on production of IL-8 in
IL-1b-activated HMC-1 (Figures 8 and 9).
Effects of BAI on IL-6 and IL-8 gene expressions in CSE-
treated and IL-1b-activated mast cells
To study effects of BAI on inflammatory cytokine gene
expression, the experiments were performed using IL-1b-
activated HMC-1. HMC-1 were treated with IL-1b (10 μg/
mL) and CSE in the presence or absence of BAI (30 μM)
for 6 hours and harvested for transcriptional analysis via
RT-PCR. IL-1b-treated HMC-1 increased IL-6 and IL-8
mRNA transcription (Figure 10). The intensities of the
cytokine and house keeping gene (HPRT) bands were mea-
sured by densitometry, and the ratio of the cytokine to the
house keeping gene was calculated and assigned as the
intensity index. In the presence of Ms (0.125 mg/mL) or Ss
(0.125 mg/mL) CSE, the expression of IL-6 and IL-8 was
increased. However, in the present of BAI, the expression
of IL-6 and IL-8 was remarkably decreased (Figure 10).
Role of NF-kB activation in the inhibitory effect of BAI on
inflammatory cytokine production from CSE-treated and
IL-1b-activated mast cells
NF-B is an important transcription factor that med-
iates the transcription of many proinflammmatory cyto-
kine genes [29,30]. In order to study the role that NF-
B plays in the inhibitory effect of BAI on inflammatory
cytokine production, NF-B activation was analyzed in
HMC-1 cultured with CSE and IL-1b (10 μg/mL) in the
presence or absence of BAI (30 μM). NF-Bt r a n s l o c a -
tion, as seen by a shift in oligonucleotide binding in
EMSA gels, was increased in the IL-1b-activated
HMC-1 (Figure 11). With the addition of Ms or Ss CSE
(0.125 mg/mL) treatment, NF-B translocation was even
higher than that of the only IL-1b-treated group (Figure
11). In the presence of BAI, NF-B translocation was
d e c r e a s e dw h e nc o m p a r e dt ot h a to ft h eI L - 1 b and
CSE-activated HMC-1 (Figure 11).
Role of IkBa proteins in the inhibitory effect of BAI on
inflammatory cytokine production from CSE-treated and
IL-1b-activated mast cells
The activation of NF-B requires phosphorylation and
proteolytic degradation of the inhibitory protein IBa
[31]. To determine whether the inhibitory activity of
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Figure 6 Effects of Baicalein (BAI, 30 μM) on production of IL-6
from Mainstream cigarette smoke extract (Ms)-treated and IL-
1b-activated HMC-1. (* indicates p < .000005 when compared with
the corresponding IL-1b + Ms groups)
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Figure 7 Effects of Baicalein (BAI, 30 μM) on production of IL-6
from Sidestream cigarette smoke extract (Ss)-treated and IL-
1b-activated HMC-1. (* indicates p < .00005 when compared with
the corresponding IL-1b + Ss groups)
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Figure 8 Effects of Baicalein (BAI, 30 μM) on production of IL-8
from Mainstream cigarette smoke extract (Ms)-treated and IL-
1b-activated HMC-1. (* indicates p < .0005 when compared with
the corresponding IL-1b + Ms groups).
Chi et al. Clinical and Molecular Allergy 2012, 10:3
http://www.clinicalmolecularallergy.com/content/10/1/3
Page 6 of 11BAI is due to its effect on IBa phosphorylation and
degradation, we used Western blot analysis to examine
the cytoplasmic levels of IBa in HMC-1 after treat-
ment with Ms or Ss CSE (both 0.125 mg/mL) and IL-1b
(10 μg/mL) in the presence or absence of BAI (30 μM).
The data showed that in the presence of IL-1b,t h e
IBa protein levels were decreased in HMC-1 (Figure
12). In cell treated with IL-1b a n dM so rS sC S E ,t h e
IBa protein levels were further decreased when com-
p a r e dt ot h a to ft h eo n l yI L - 1 b-activated group (Figure
12). With the addition of BAI, the IBa protein levels
were markedly increased when compared to that of the
IL-1b- and CSE-activated HMC-1 (Figure 12).
Discussion
Inflammatory cytokines are important factors in chronic
inflammation, allergy, asthma, atherogenesis, and auto-
immune diseases. Human mast cells play an integral
role in the inflammatory response by accumulating at
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Figure 9 Effects of Baicalein (BAI, 30 μM) on production of IL-8
from Sidestream cigarette smoke extract (Ss)-treated and IL-
1b-activated HMC-1. (* indicates p < .0005 when compared with
the corresponding IL-1b + Ss groups)
Figure 10 RT-PCR analysis of effects of BAI on the gene expression of IL-6 and IL-8 in cigarette smoke extracts (CSE: Mainstream, Ms,
and Sidestream, Ss)-treated and IL-1b- activated HMC-1 cells. HMC-1 were treated with IL-1b (10 μg/mL) and CSE in the presence or
absence of BAI (30 μM) for 6 hours and harvested for transcriptional analysis via RT-PCR. The intensities of the cytokine and house keeping gene
(HPRT) bands were measured by densitometry, and the ratio of the cytokine to the house keeping gene was calculated and assigned as the
intensity index. IL-1b-treated HMC-1 increased IL-6 and IL-8 mRNA transcription. In the presence of Ms (0.125 mg/mL) or Ss (0.125 mg/mL) CSE,
the expression of IL-6 and IL-8 was increased further. However, in the addition of BAI, the expression of IL-6 and IL-8 was remarkably decreased.
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Figure 11 Effects of BAI on NF-B translocation in IL-1b-activated and cigarette smoke extract (CSE: Mainstream, Ms, and Sidestream,
Ss)-treated HMC-1 cells. HMC-1 were treated with IL-1b (10 μg/mL) and CSE (0.125 mg/mL) in the presence or absence of BAI (30 μM) for 24
hours. NF-B translocation was analysed by a shift in oligonucleotide binding in EMSA gels. Densitometric analysis of NF-B was expressed as
integrated intensity.
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Figure 12 Effects of BAI on IBa proteins levels in cytoplasm of IL-1b-activated and cigarette smoke extract (CSE: Mainstream, Ms,
and Sidestream, Ss)-treated HMC-1 cells. HMC-1 were treated with IL-1b (10 μg/mL) and CSE (0.125 mg/mL) in the presence or absence of
BAI (30 μM) for 24 hours. Cytoplasmic extracts were prepared from each sample, and levels of IBa proteins were analysed by Western blot.
Densitometric analysis of NF-B was expressed as integrated intensity.
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Page 8 of 11sites of inflammation and mediating the production of
inflammatory cytokines, such as IL-6 and IL-8 [32].
IL-6 promotes the formation of acute phase proteins
in the liver during the acute phase response and initiates
B-cell transformation into plasma cells. IL-8 serves as a
chemo-attractant for neutrophils, macrophages, and
T-cells.
The expression of various inflammatory cytokines is
regulated by transcription factors. The activation of the
NF-B transcription plays an important role in inflam-
mation through its ability to induce the transcription of
proinflammatory genes [33]. The NF-Be x i s t sa sa
homo- or hetero-dimer comprised of 65-kDa (Rel A or
p65) and 50 kDa (p50) DNA-binding proteins, and is a
ubiquitously expressed transcription factor that exists in
a latent state in the cytoplasm bound to inhibitory pro-
teins, IBa. Following an activation stimulus, IBa
undergoes degradation, allowing free NF-Bt ol o c a l i z e
to the nucleus where it binds to specific recognition ele-
ments in the promoter regions of various genes. This
can then initiate transcription of cytokines.
Cigarette smoking is linked to cancer, cardiovascular
disease, respiratory disease, and other adverse effects
such as atherosclerosis [15]. However, the underlying
basic mechanisms involved in the processes that lead to
diseases induced by cigarette smoke components is not
much known. Previously, we have reported that cigarette
smoke extract (CSE) significantly increased IL-6 and IL-
8p r o d u c t i o ni nI L - 1 b-activated human mast cell-1
(HMC-1). In this study, we aimed to examine effects
and mechanisms of CSE on the expression of inflamma-
tory cytokines in mast cells.
Our results showed that both Main- and Side-stream
CSE increase IL-6 and IL-8 production in IL-1b-activated
mast cells (Figures 1, 2, 3, and 4). Moreover, RT-PCR
analysis of the gene expression of the inflammatory cyto-
kines, IL-6 and IL-8, was markedly increased in smoke
extract-treated and IL-1b-activated HMC-1 (Figure 10).
This suggests that the ability of CSE to increase cytokine
production is through the increase of cytokine mRNA
transcription. Furthermore, CSE increased NF-Bb i n d -
ing activity (Figure 11) and decreased IBa proteins in
the cytoplasm of IL-1b-activated mast cells (Figure 12).
These results suggest CSE enhances the NF-B activation
via inhibition of IBa phosphorylation and degradation.
In spite of advances in the pharmacological management
of the above mentioned chronic inflammatory diseases
and symptoms, to discover effective, alternative anti-
inflammatory reagents is still needed. Several Chinese her-
bal medicines have anti-bacterial and viral properties and
been used for treatment of chronic inflammation. Pre-
viously, we have screened several Chinese herbal medi-
cines and found that the compound Baicalein (BAI)
isolated from Huangqin (Scutellaria baicalensis Georgi)
has a great inhibitory effect on the production of IL-6
from IL-1b-activated HMC-1 in a dose dependent fashion
[28]. In this study we further investigate inhibitory effects
and mechanisms of BAI on inflammatory cytokine expres-
sion from IL-1b-activated and CSE-treated human mast
cells.
The results showed that BAI (1.8 to 30 μM) signifi-
cantly inhibited production of IL-6 and IL-8 in a dose-
dependent manner in IL-1b-activated HMC-1 (Figure 5).
Since BAI 30 μM was the most effective concentration,
we only used this dose to treat smoke extract-treated and
IL-1b-activated HMC-1 cells. We found BAI also signifi-
cantly inhibited production of IL-6 and IL-8 in smoke
extract-treated and IL-1b-activated HMC-1 (Figures 6, 7,
8, and 9). The cell viabilities of the drug groups and med-
ium control cultures ranged from 90 to 98%. Thus, this
inhibitory effect appears not due to the toxic effect of
BAI on HMC-1 cells. Moreover, the gene expression,
analyzed by RT-PCR, of these inflammatory cytokines
was markedly decreased in smoke extract-treated and IL-
1b-activated HMC-1 (Figure 10) when BAI was present.
This suggests that the inhibitory effect of BAI on cyto-
kine productions is through the decrease of cytokine
mRNA transcription.
Previously, glucocorticoids that have frequently been
used for the treatment of inflammatory diseases, allergy,
and autoimmune diseases were thought to suppress NF-
B activation. Glucocorticoids induce the transcription of
IBa, resulting in an enlarged IBa pool, and therefore
reduced active NF-B in the nucleus [34]. Additionally,
12-lipoxygenase (12-LOX) has been implicated as a media-
tor of inflammation, atherosclerosis, and cancer [35-37].
Several in vitro studies have suggested 12/15-LOX pro-
ducts to be co-activators of peroxisomal proliferator acti-
vating-receptors (PPAR), regulators of cytokine
generation, and modulators of gene expression related to
inflammation resolution. The dampening effect of PPAR
on inflammation is via their inhibitory activity on expres-
sion of NF-B [38-40]. As BAI is known as a 12-LOX
inhibitor, we speculated the mechanism by which BAI
inhibited inflammatory cytokines was through the NF-B/
IBa pathway. Therefore, we analyzed NF-B activation
and examined the cytoplasmic levels of IBa in HMC-1
after treatment with IL-1b a n dC S Ei nt h ep r e s e n c eo r
absence of BAI. Our data showed BAI decreased NF-B
binding activity (Figure 11) and increased IBa proteins in
the cytoplasm of IL-1b-activated and CSE-treated mast
cells (Figure 12). The results suggest BAI inhibits the NF-
B activation via inhibition of IBa phosphorylation and
degradation.
In recent studies, an important flavonoid, quercetin,
has been reported to exert a strong inhibitory effect on
the production of IL-6, MCP-1, and histidine decarboxy-
lase (HDC) mRNA transcription from mast cells [41-43].
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also strongly inhibit production of inflammatory cyto-
kines of IL-6 and IL-8 from activated mast cells through
the decrease of mRNA transcription. Ultimately it is
hoped that BAI will be a possible candidate for future
development of novel anti-inflammatory therapies.
Conclusions
Cigarette smoke extract (CSE) significantly increased IL-
6 and IL-8 production in IL-1b-activated human mast
cell-1 (HMC-1). CSE derived increases in cytokine pro-
duction is due to the increase of cytokine mRNA tran-
scription. Furthermore, CSE increased NF-Bb i n d i n g
activity and decreased IBa proteins in the cytoplasm of
IL-1b-activated mast cells. The results may partially
explain why cigarette smoke contributes to lung and
cardiovascular diseases.
In searching for effective drugs to treat inflammatory
related diseases, we found Baicalein from Chinese herbal
medicine possessed a strong inhibitory effect on produc-
tion of selected inflammatory cytokines from human
mast cells. The inhibitory mechanism appears to be due
to inhibition of NF-B activation pathway and IBa
phosphorylation and degradation. This inhibitory effect
of Baicalein on the expression of inflammatory cytokines
indicates its usefulness in the development of novel anti-
inflammatory therapies.
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